END-OF-TREATMENT QUANTITATIVE HBSAG < 500 IU/ML CAN PREDICT SUSTAINED REMISSION AND HBSAG LOSS AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B ArticleAbdurakhmanov D., Panevkina S., Ibragimov E., Rozina T., Nikulkina E., Mazurchik N.HEPATOLOGY. Том 72. 2020.
HBSAG LEVELS AS A GUIDE FOR FINITE TREATMENT DURATION OF CHRONIC HEPATITIS B ArticleAbdurakhmanov D., Ibragimov E., Rozina T., Nikulkina E., Mazurchik N.Clinics and Research in Hepatology and Gastroenterology. Том 43. 2019. С. e73-e75
THE SPECIFICITY AND SENSITIVITY OF THE CARBHYDRATE-DEFICIENT TRANSFERRIN IN THE DIAGNOSIS OF SEVERE ACUTE ALCOHOLIC HEPATITIS ArticleOgurtsov P., Tarasova O., Mazurchik N.Conference Abstracts 26th Annual Conference of APASL.(China, Shanghai, Fefruary 15-19, 2017). No: PP0002 (S195-S196). Том 11. 2017. С. 195-196
HBSAG QUANTITY FOR MONITORING OF HEPATITIS B VIRUS INFECTION IN INACTIVE CARRIERS ArticleTarasova O., Garagulya E., Mazurchik N., Ogurtsov P.Hepatology International. Том Vol10. 2016. С. 213-213
LEVELS OF MICRO-RNA-122, MICRO-RNA-199A, MICRO-RNA-196, MICRO-RNA-491 AND MICRO-RNA-16 AND ANTIVIRAL THARAPY IN CHRONIC HCV-INFECTION ArticleFedotova A., Tarasova O., Kritskaya L., Gimadiev R., Abramov A., Mazurchik N., Kochetov A., Ogurtsov P.AASLD/EASL Special Conference on Hepatitis C. New York, September 12-13, 2014. 2014. С. 204-205
EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C WITH PEG-IFN ALPHA-2B AND RIBAVIRIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH HCV-1 GENOTYPE AND INSULIN RESISTANCE ArticleKhafisova O.O., Tarasova O., Mazurchik N., Ogurtsov P.P.HEPATOLOGY. Том 58. 2013.
COMBINED THERAPY OF PREDNISOLONE AND PENTOXIFYLLINE IN SEVER ACUTE ALCOHOLIC HEPATITIS ArticleTarasova O., Mazurchik N., Ogurtsov P.Hepatology International. Том Vol7. 2013. С. 39-40